Americans for Safe Access also has links to research studies suggesting that cannabis may help in the treatment or prevention of Alzheimer's disease and cancer, while the International Association for Cannabis as Medicine highlights the following medical uses

Alzheimer's disease is the leading cause of dementia among the elderly, and with the ever-increasing size of this population, cases of Alzheimer's disease are expected to triple over the next 50 years.

Consequently, the development of treatments that slow or halt the disease progression have become imperative to both improve the quality of life for patients as well as reduce the health care costs attributable to Alzheimer's disease. Here, we demonstrate that the active component of marijuana, Δ9-tetrahydrocannabinol (THC), competitively inhibits the enzyme acetylcholinesterase (AChE) as well as prevents AChE-induced amyloid β-peptide (Aβ) aggregation, the key pathological marker of Alzheimer's disease. Computational modeling of the THC-AChE interaction revealed that THC binds in the peripheral anionic site of AChE, the critical region involved in amyloidgenesis.

Compared to currently approved drugs prescribed for the treatment of Alzheimer's disease, THC is a considerably superior inhibitor of Aβ aggregation, and this study provides a previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.

Watch the video below. In the meantime, would you like to see more analysis about this video in The Canadian National Newspaper? Then, show your support. Make a member-pledge donation, in support of our Membership Drive.

Do you seek to help spread further social awareness? We also welcome the submission of well written articles and editorials.

The Canadian can only continue to publish investigative articles in such areas, with the donations from members of the public in Canada, the U.S., and abroad. Consider making a donation of $10, $25. $50.00, $75.00, $100.00 or more. Donors are eligible to receive our first collector's print edition in mail. Alternatively, you can send us a note to be placed on our special email list of members. Member-donors can also suggest articles or commentaries to be published in The Canadian.

The Canadian is a socially progressive and not-for-profit national newspaper, with an international readership. We provide an alternative to the for-profit commercial focused media, which often censors vital information and perspective of potential interest to the diverse Canadian public, and other peoples internationally.

E-mail: editorial@agoracosmopolitan.com to donate via PayPal.

Internet site references:

http://www.cannabisscience.com/images/downloads/alzheimers3.pdf